Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: Mass Spectrom Rev. 2022 Sep 27;43(2):289–326. doi: 10.1002/mas.21811

TABLE 4.

A summary of different approaches used to characterize nTyr using LC-MS/MS analysis

Methods used Samples analyzed # Sites # Proteins References

WB 3-nTyr antibody Human astrocytoma tissue 20 18 Peng et al. (2015)
Precursor ion scanning In vitro nitrated Bovine fibrinogen 5 - Luo et al. (2015)
Fluorogenic enrichment Yeast lysate (in vivo) 14 14 Kang et al. (2015)
Solid-phase chemical capture of aromatic amines Peroxynitrite treated rat brain lysate 244 144 Nuriel et al. (2016)
Protein-level IP anti-3-nTyr antibody Secondhand smoke exposed rat’s brain lysate - 29 Kobeissy et al. (2017)
Peptide-level IP using anti-3-nTyr antibody In vitro nitrated whole-cell lysate poly(I:C) treated mouse lung tissue Cell lysate: 18811 Lung: 237 Cell lysate: 907 Lung: 147 peptides Zhao et al. (2017)
2DGE, 3-nTyr WB, in-gel digestion, LC-MS/MS In vitro nitrated beef heart mitochondria 6 5 Kohutiar et al. (2018)
Filter-aided sample preparation (FASP) 1 targeted detection using Skyline Peroxynitrite treated laminin 148 - Lorentzen et al. (2019)
2DGE and MALDI-TOF/TOF Ischemia reperfused rat heart - 8 Tatarkova et al. (2019)
Anti-3-nTyr affinity, in-gel digestion, and LC-MS/MS analysis In vitro nitrated S. meliloti proteins 2 2 Cazalé et al. (2020)
3-nTyr antibody WB, in-gel digestion, and LC-MS/MS, PRM analysis using Skyline Sodium nitroprusside treated CDKA;1 from maize embryo 2 - Méndez et al. (2020)
Untargeted LC-MS/MS analysis for treated SRM analysis for in vivo Peroxynitrite treated and in vivo ischemic fibrinogen Treated: 20 In vivo SRM: 9 - Medeiros et al. (2021)
Result validation by comparing MS/MS spectra to synthetic nitropeptides Hepatocyte nuclei from control and ethanol-exposed mice liver 6 4 Kriss et al. (2021)

Abbreviation: CDKA, cyclin-dependent kinase A.